Alkon Daniel L. 4
4 · Synaptogenix, Inc. · Filed Jul 15, 2021
Insider Transaction Report
Form 4
Alkon Daniel L.
DirectorChief Scientific Officer
Transactions
- Award
Common Stock, par value $0.0001 per share
2021-07-13+80,000→ 91,484 total
Footnotes (1)
- [F1]Includes 80,000 restricted stock units granted on July 13, 2021 (the "Grant Date") under the Issuer's 2020 Equity Incentive Plan which will vest 50% on the six month anniversary of the Grant Date and the remaining 50% on the one year anniversary of the Grant Date.